Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bushenzhuanggu refers to a traditional Chinese medicine (TCM) formulation used primarily for the treatment of osteoporosis and bone-related disorders. The name translates as "tonify kidney and strengthen bone," reflecting its TCM principle of nourishing kidney function to support bone health. The formulation is typically available as capsules or pills and may contain a combination of herbal ingredients such as Achyranthes bidentata, which has demonstrated anti-inflammatory, osteogenic, and immune-modulating effects[1][5][8]. Clinical studies have shown that bushenzhuanggu can improve bone mineral density and modulate cytokines related to bone metabolism in patients with primary osteoporosis[6][8][9]. Its mechanism is believed to involve promoting osteoblast activity, enhancing mineralization, reducing inflammation, and regulating immune responses relevant to bone health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bushenzhuanggu.